secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-04-26T23:59:59+00:00
Accession:  0001493152-23-013662
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX receives NYSE American delisting notice for low stockholders' equity; faces potential delisting by May 17, 2023
--------------------------------------------------------------------------------

- NYSE American cited AgeX for stockholders' equity below $2M, $4M, and $6M thresholds with sustained losses.
- AgeX must comply or show progress by May 17, 2023, or delisting proceedings will be initiated.
- If delisted, AgeX plans to have its common stock quoted on an electronic interdealer quotation system (OTC).
- AgeX remains subject to conditions from prior deficiency letters regarding stockholders' equity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223013662/0001493152-23-013662-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223013662/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-013662

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer